Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea
Sponsor: Janssen Korea, Ltd., Korea
Summary
The purpose of this study is to evaluate how safe Opsynvi (macitentan/tadalafil fixed-dose combination) is in adult participants with pulmonary arterial hypertension under routine clinical practice in Korea. Pulmonary arterial hypertension is a condition where the blood vessels that carry blood from the heart to the lungs become narrowed or stiff.
Official title: A Prospective Observational Study to Evaluate Safety and Effectiveness of Opsynvi (Macitentan/Tadalafil Fixed Dose Combination) in Adult Patients With Pulmonary Arterial Hypertension in Korea
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
333
Start Date
2026-11-02
Completion Date
2032-10-29
Last Updated
2026-11-03
Healthy Volunteers
No
Conditions
Locations (1)
Pusan National University Hospital
Busan, South Korea